Erika Ayers Badan: What Do You Want?
Please meet Cynthia Pong. She came to me by way of super-connector and personal board director an occasional SVU actor, Sarah Storm. Cynthia Pong packs…
Thought Leader: Erika Ayers Badan
Why Does the U.S. Have So Few Confirmed Coronavirus Cases?
By Scott Gottlieb, MD ( original source The Wall Street Journal)
“A mere 15 cases of the Wuhan coronavirus have been diagnosed in the U.S., according to the Centers for Disease Control and Prevention, and that number hasn’t budged in a week. But the true number of cases is unknown, because the U.S. is testing only those who recently arrived from China or have been in close contact with confirmed patients. Public-health authorities need to be prepared for a wider outbreak.
The CDC says it will set up a pilot program in five states to screen some patients with unexplained lung infections. But that program hasn’t started, so we can only hope that cases didn’t get into the U.S. undetected and begin spreading. It’s important not to overstate the danger: If thousands of people were infected in, say, New York, more patients would be showing up at hospitals with serious lung infections. The outbreak would be obvious. But since most people with the virus suffer only a mild illness, dozens and perhaps even hundreds of cases may be circulating undetected. Here are five steps public-health authorities should take to get ready:”
Click here to read more
Relevant and recent posts
Patrick McGee: Foreign Affairs Best Books of 2025
McGee, a Financial Times journalist, brings his investigative skills to bear on the fascinating history of how, over a quarter century, China and the technology…
Thought Leader: Patrick McGee
Dr. Sanjay Gupta: How to Identify Medical Misinformation
As a practicing neurosurgeon and CNN’s chief medical correspondent, Dr. Sanjay Gupta can spot false health claims from a mile away. Still, he recently became…
Thought Leader: Sanjay Gupta
More with this speaker
Scott Gottlieb on China’s biotech strategy
Thought Leader: Scott Gottlieb
Scott Gottlieb: China’s edge over U.S. biotech
Thought Leader: Scott Gottlieb